CDCTF(CDCTF)
CDCTF
No analyst ratings available
No analyst price targets available for CDCTF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $41.81B | $43.95B | $43.90B | $43.75B | $44.55B |
| Low | $41.76B | $43.26B | $43.52B | $43.37B | $44.16B |
| High | $41.86B | $44.65B | $44.28B | $44.13B | $44.94B |
| EBITDA Avg | $14.32B | $15.05B | $15.04B | $14.99B | $15.26B |
| Low | $14.30B | $14.82B | $14.91B | $14.86B | $15.13B |
| High | $14.34B | $15.29B | $15.17B | $15.12B | $15.39B |
| EBIT Avg | $12.77B | $13.42B | $13.40B | $13.36B | $13.60B |
| Low | $12.75B | $13.21B | $13.29B | $13.24B | $13.48B |
| High | $12.78B | $13.63B | $13.52B | $13.47B | $13.72B |
| Net Income Avg | $61M | $58M | $56M | $57M | $55M |
| Low | $60M | $58M | $56M | $56M | $54M |
| High | $62M | $59M | $57M | $57M | $55M |
| EPS Avg | $291.70 | $278.68 | $269.88 | $270.77 | $261.52 |
| Low | $288.41 | $275.53 | $266.83 | $267.71 | $258.57 |
| High | $295.00 | $281.83 | $272.93 | $273.83 | $264.48 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $7.01B | $11.91B | $8.23B |
| Low | $4.47B | $7.60B | $5.25B |
| High | $9.55B | $16.21B | $11.20B |
| EBITDA Avg | $2.40B | $4.08B | $2.82B |
| Low | $1.53B | $2.60B | $1.80B |
| High | $3.27B | $5.55B | $3.84B |
| EBIT Avg | $2.14B | $3.64B | $2.51B |
| Low | $1.37B | $2.32B | $1.60B |
| High | $2.91B | $4.95B | $3.42B |
| Net Income Avg | $126M | $4.20B | $919M |
| Low | $67M | $2.23B | $487M |
| High | $185M | $6.18B | $1.35B |
| EPS Avg | $3.78 | $126.39 | $27.64 |
| Low | $2.00 | $66.96 | $14.65 |
| High | $5.56 | $185.82 | $40.64 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 |